The European Medicines Agency (EMA) has received an application for approval of the Oxford/AstraZeneca Covid-19 vaccine.
A decision on the conditional marketing authorisation of the vaccine could be issued by 29th January, the EMA said.
The assessment of the vaccine will proceed under an accelerated timeline. If approved, it would be the third Covid-19 vaccine given the green light in the EU, after Pfizer/BioNTech and Moderna.
A conditional marketing authorisation results in a fast-tracked approval during public health emergencies valid throughout all EU member states.